Similar Papers

Paper Title
Journal
Date
Author
Clinical study of thermotherapy of HIFU in combination with intra - arterial infusion chemothera-py in treatment of advanced pancreatic cancer
...
-
, et. al. ...
25 Apr 2009
PD-1 antibody combined with paclitaxel (albumin bound) and gemcitabine as first-line therapy in patients with metastatic pancreatic cancer.
Jiujie Cui ... Xiao Zhang
Journal of Clinical Oncology | VOL. 38
Jiujie Cui, et. al.Jiujie Cui ... Xiao Zhang
20 May 2020
NALIRIFOX vs FOLFIRINOX vs gemcitabine plus nab-paclitaxel as first-line treatment of advanced pancreatic cancer: An individual patient data pooled analysis of phase 3 registration trials.
Federico Nichetti ... Chiara Carlotta Pircher
Journal of Clinical Oncology | VOL. 41
Federico Nichetti, et. al.Federico Nichetti ... Chiara Carlotta Pircher
01 Jun 2023
The preliminary results of high intensity focused ultrasound (HIFU) treatment for advanced pancreatic cancer
...
-
, et. al. ...
25 Sep 2014
View more papers

More From: Gastrointestinal Tumors

Paper Title
Journal
Date
Author
Clinicopathological features and prognostic significance of SYT8 in patients with colorectal cancer who received curative surgery
Jin Zhu ... Jun Qian
Gastrointestinal Tumors | VOL. 12
Jin Zhu, et. al.Jin Zhu ... Jun Qian
01 Jan 2025
ENO1 regulates trastuzumab resistance in gastric cancer cells through IRP1
Lei Wang ... Xinyi Ding
Gastrointestinal Tumors | VOL. 12
Lei Wang, et. al.Lei Wang ... Xinyi Ding
01 Jan 2025
Colorectal cancer liver metastases: immune environment and therapeutic perspectives
Junjie Wen ... Dian Hu
Gastrointestinal Tumors | VOL. 12
Junjie Wen, et. al.Junjie Wen ... Dian Hu
01 Jan 2025
The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma
Ayma Aftab ... Liaqat Ali
Gastrointestinal Tumors | VOL. 12
Ayma Aftab, et. al.Ayma Aftab ... Liaqat Ali
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.